Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

I1. Adult Vaccines

Poster Session: Adult Vaccines

(P-41) Effectiveness of recombinant zoster vaccine against postherpetic neuralgia in a real-world setting

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Co-Author(s)

  • Ousseny Zerbo, PhD

    Research Scientist
    Division of Research Kaiser Permanente Vaccine Study Center
    Oakland, CA, United States

  • JB

    Joan Bartlett, MPH, MPP

    Kaiser Permanente Vaccine Study Center
    Oakland, California, United States

  • BF

    Bruce Fireman, MA

    Research Scientist
    Division of Research Kaiser Permanente Vaccine Study Center
    Oakland, California, United States

  • KG

    Kristin Goddard, MpH

    Sr. Research Project Manager
    Division of Research Kaiser Permanente Vaccine Study Center
    Oakland, California, United States

  • JD

    Jonathan Duffy, MD

    CDC
    Atlanta, Georgia, United States

  • JG

    Jason Glanz, PhD

    Senior Research Investigator
    Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado
    Denver, Colorado, United States

  • AN

    Allison L. Naleway, PhD

    Senior Investigator
    Kaiser Permanente Center for Health Research
    Portland, Oregon, United States

  • JD

    James Donahue, DVM,PhD, MPH

    Investigator
    Marshfield Clinic Research Institute, Marshfield, Wisconsin
    Marshfield, Wisconsin, United States

  • TA

    Tara C. Anderson, DVM, PhD, MPH

    Centers for Disease Control and Prevention
    Atlanta, Georgia, United States

    • Presenting Author(s)

  • Nicola P. Klein, MD, PhD (she/her/hers)

    Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
    Division of Research Kaiser Permanente Vaccine Study Center
    Oakland, California, United States